Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Nashville TN, Gainesville GA, Greenville SC,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07207811

Phase 3, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Nashville TN, Huntsville AL, Louisville KY, Atlanta GA,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

for
Coronary Artery Disease
Location: Nashville TN, Louisville KY, Lexington KY, Atlanta GA,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399692

Phase 3, Recruiting

Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)

for
Tricuspid Regurgitation, Tricuspid Valve Disease,
Location: Nashville TN, Cincinnati OH, Charleston SC,
Sponsor: VDyne, Inc.

Sex: All

Age: 18+

Code: NCT05848284

Recruiting

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

for
Persistent Corneal Epithelial Defect
Location: Nashville TN, Atlanta GA, Shelby NC, Carmel IN,
Sponsor: Glaukos Corporation

Sex: All

Age: 2+

Code: NCT05966493

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

for
Coronary Artery Disease
Location: Nashville TN, Atlanta GA, Cincinnati OH,
Sponsor: Kardion Inc

Sex: All

Age: 18 - 70+

Code: NCT06445608

Recruiting

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

for
Type 2 Diabetes, Cardiovascular Risk
Location: Nashville TN, Lexington KY, Bristol TN, Montgomery AL,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 45+

Code: NCT07797335

Phase 3, Recruiting

Pharmacogenomic Testing Of the Elderly To Reduce Morbidity

for
Genetics of Drug Metabolism
Location: Nashville TN, Tallahassee FL, Houston TX,
Sponsor: General Genetics Corporation

Sex: All

Age: 18+

Code: NCT02095769

Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Nashville TN, Jeffersonville IN, Cincinnati OH,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Nashville TN, Homewood AL, Jeffersonville IN,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

for
Metastatic Castration Resistant Prostate Cancer
Location: Nashville TN, Jeffersonville IN, Charlotte NC,
Sponsor: ORIC Pharmaceuticals

Sex: Male

Age: 18+

Code: NCT07723248

Phase 3, Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Nashville TN, Birmingham AL, Atlanta GA, Durham NC,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07206225

Phase 1, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Nashville TN, Jeffersonville IN, Atlanta GA,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase 2, Recruiting

ResQ133A-NMIBC: Intravesical Recombinant Mycobacterium (rMBCG) in Participants With NMIBC Eligible to Receive Intravesical Tice BCG

for
NMIBC
Location: Nashville TN, Atlanta GA, Troy MI, Cynwyd PA,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06800963

Phase 1, Phase 2, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for
Non-Muscle Invasive Bladder Cancer
Location: Nashville TN, Knoxville TN, Germantown TN, St Louis MO,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase 3, Recruiting

Prevail Global Study

for
Coronary Artery Disease
Location: Nashville TN, Huntsville AL, Birmingham AL,
Sponsor: Medtronic Vascular

Sex: All

Age: 18+

Code: NCT06535854

Recruiting

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

for
Prostate Cancer, Prostatic Neoplasms
Location: Nashville TN, Birmingham AL, Indianapolis IN,
Sponsor: Clarity Pharmaceuticals Ltd

Sex: Male

Age: 18+

Code: NCT06056830

Phase 3, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Nashville TN, Greenwood IN, Gahanna OH, Chicago IL,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase 2, Recruiting

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Nashville TN, Jeffersonville IN, Atlanta GA,
Sponsor: CG Oncology, Inc.

Sex: All

Age: 18+

Code: NCT06567743

Phase 2, Recruiting

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

for
Prostate Cancer,
Location: Nashville TN, Jeffersonville IN, Durham NC,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT04729114

Phase 1, Recruiting